This list is based on the watchlists of people on Stock Events who follow GBS. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Show more...
FAQ
What is GBS stock price today?▼
The current price of GBS is $0.47 USD — it has decreased by -0.57% in the past 24 hours. Watch GBS stock price performance more closely on the chart.
What is GBS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GBS stocks are traded under the ticker GBS.
What is GBS revenue for the last year?▼
GBS revenue for the last year amounts to 177.79 USD.
What is GBS net income for the last year?▼
GBS net income for the last year is -4.85M USD.
How many employees does GBS have?▼
As of April 06, 2026, the company has 7 employees.
In which sector is GBS located?▼
GBS operates in the Manufacturing sector.
When did GBS complete a stock split?▼
GBS has not had any recent stock splits.
Where is GBS headquartered?▼
GBS is headquartered in New York, US.